ghazi52
PDF THINK TANK: ANALYST
![](/styles/default/xenforo/ranks/FieldMarshal.jpg)
- Joined
- Mar 21, 2007
- Messages
- 102,392
- Reaction score
- 106
- Country
- Location
UAE approves Sinopharm's protein-based vaccine
The United Arab Emirates has approved emergency use of Sinopharm's protein-based Covid-19 vaccine and it will be available to the public as a booster dose starting January 2022, Reuters quotes the health ministry as saying.
The vaccine will be produced and distributed by a joint venture between the UAE's Group 42 and China National Biotec Group a unit of China National Pharmaceutical Group (Sinopharm), the ministry said in a statement on state media on Monday.
The UAE, a federation of seven emirates, on Monday reported 1,732 new coronavirus cases and one death. Authorities, who do not give a breakdown for each emirate, said around 91 per cent of the population of some 10 million had been fully vaccinated.
In this file photo, a health worker counts used vials of Sinopharm's coronavirus disease vaccine at a vaccination centre. — Reuters/File
The United Arab Emirates has approved emergency use of Sinopharm's protein-based Covid-19 vaccine and it will be available to the public as a booster dose starting January 2022, Reuters quotes the health ministry as saying.
The vaccine will be produced and distributed by a joint venture between the UAE's Group 42 and China National Biotec Group a unit of China National Pharmaceutical Group (Sinopharm), the ministry said in a statement on state media on Monday.
The UAE, a federation of seven emirates, on Monday reported 1,732 new coronavirus cases and one death. Authorities, who do not give a breakdown for each emirate, said around 91 per cent of the population of some 10 million had been fully vaccinated.
![In this file photo, a health worker counts used vials of Sinopharm's coronavirus disease vaccine at a vaccination centre. — Reuters/File In this file photo, a health worker counts used vials of Sinopharm's coronavirus disease vaccine at a vaccination centre. — Reuters/File](/proxy.php?image=https%3A%2F%2Fi.dawn.com%2Fprimary%2F2021%2F12%2F61cab4160086f.jpg&hash=1a0b5a544a03513d57a9dcead4a3dba8)
In this file photo, a health worker counts used vials of Sinopharm's coronavirus disease vaccine at a vaccination centre. — Reuters/File